Overview
Biofaktor has been developing pharmaceutical preparations for humans and animals since 2000, including otolaryngology products as well as veterinary medicines and nutritional preparations. The company also provides CMO contract manufacturing, operates quality systems compliant with ISO 9001:2015 and HACCP, and holds an MDR certificate for Class IIb medical devices.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2010-12-31. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $450.4K$450,357 |
Buildings and premises | $7.9M$7,929,080 |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 26, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | E.ON Polska S.A. | |
| Feb 13, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Prezydent Miasta Gorzów Wielkopolski |
Tenders
No recorded participation in tenders.
Trademarks
Biofaktor holds 6 active trademarks registered with the Polish Patent Office. 90 marks have expired or were not registered. The first mark was filed in 1994.
| Mark | Protected until | |
|---|---|---|
| HYANALIN | May 6, 2034 | |
| DogShield jakość ma znaczenie | May 9, 2034 | |
| MAMMASTIN(word) | Dec 7, 2030 | |
| UBERMAST(word) | Dec 7, 2030 | |
| BIOXYMUTIN(word) | Apr 30, 2029 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
A member of the management board independently, a commercial proxy independently.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dariusz Andrzej Grabikowski (60) | 150 | $20,259.32 | 49.6689% |
Others | 152 | $20,529.44 | 50.3311% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Phytopharm KlękaS.A. | $46,154,888.31 | phytopharm.pl | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $40,633,950.51 | biomed.pl | ||
| Curtis Health CapsS.A. | $34,513,094.78 | chc.com.pl | ||
| VipharmS.A. | $30,660,173.61 | vipharm.pl | ||
| EXIM Pharmasp. z o.o. | $24,694,130.27 | eximpharma.eu | ||
| Fagronsp. z o.o. | $21,715,187.73 | fagron.pl | ||
| Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o. | $21,462,728.43 | farmapol.pl | ||
| Przedsiębiorstwo Produkcyjno-Handlowe EwaS.A. | $14,322,437.53 | ewa-sa.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| Labofarmsp. z o.o. | $6,814,569.78 | labofarm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-09-05 | Address change (Czysta 4, 96-100, Skierniewice → Podmiejska 15 C, 66-400, Gorzów Wielkopolski) | |
| 2002-04-24 | Share capital change (150,000.00 PLN → 151,000.00 PLN) | |
| 2001-10-17 | Entered in the register |
FAQ
Last updated: 2026-10-07